Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18371
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCharalabopoulos, K.en
dc.contributor.authorKotsalos, A.en
dc.contributor.authorBatistatou, A.en
dc.contributor.authorCharalabopoulos, A.en
dc.contributor.authorPeschos, D.en
dc.contributor.authorVezyraki, P.en
dc.contributor.authorKalfakakou, V.en
dc.contributor.authorMetsios, A.en
dc.contributor.authorCharalampopoulos, A.en
dc.contributor.authorMacheras, A.en
dc.contributor.authorAgnantis, N.en
dc.contributor.authorEvangelou, A.en
dc.date.accessioned2015-11-24T18:52:12Z-
dc.date.available2015-11-24T18:52:12Z-
dc.identifier.issn1791-7530-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18371-
dc.rightsDefault Licence-
dc.subjectAdenocarcinoma/*metabolism/secondaryen
dc.subjectCarcinoembryonic Antigen/*blooden
dc.subjectCase-Control Studiesen
dc.subjectFemaleen
dc.subjectFluorometryen
dc.subjectHumansen
dc.subjectImmunoenzyme Techniquesen
dc.subjectImmunoradiometric Assayen
dc.subjectIntestinal Neoplasms/*metabolism/pathologyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectNeoplasm Stagingen
dc.subjectPrognosisen
dc.subjectSelenium/*metabolismen
dc.subjectStomach Neoplasms/*metabolism/pathologyen
dc.subjectTumor Markers, Biological/*blooden
dc.titleSerum and tissue selenium levels in gastric cancer patients and correlation with CEAen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/19661375-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2009-
heal.abstractBACKGROUND: An inverse relationship between selenium (Se) intake and cancer mortality is evident in humans. MATERIALS AND METHODS: In eighty patients who had been operated on for primary gastric cancer, serum Se and carcinoembryonic antigen (CEA) levels were measured preoperatively using a fluorometric and immunoradiometric assay (IRMA), respectively. RESULTS: The serum Se levels were 43+/-6.3 microg l(-1) in the patient group and 68.7+/-4.5 microg l(-1) in healthy individuals (p<0.001). The serum CEA was 12+/-1.9 U ml(-1) in the gastric cancer patients and 2.1 U ml(-1) in the control group (p<0.001). The Se tissue concentrations were 2,640+/-220 mg g(-1) in excised neoplastic tissue and 685+/-115 mg g(-1) in non-neoplastic tissue (p<0.001). An inverse correlation between Se and CEA serum levels was found (r=-0.782). There was no correlation between serum/tissue Se concentration and disease stage/histological type or gender in the patient group.en
heal.journalNameAnticancer Resen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Batistatou-2009-serum and tissue.pdf53.14 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons